Technical Data
C5067-91A
Chondroitin 5 Sulfate Proteoglycan (Neuroglycan C, Acidic Leucine-rich EGF-like Domain-containing Brain Protein, CSPG5)
Description:
Chondrotin sulfate proteoglycan 5 may act as a growth and differentiation factor in neuritogenesis. It may also induce ERBB3 activation. It is expressed in the brain only and localises to the cell membrane; endoplasmic reticulum and golgi membranes; and in neurons to the synaptic junctions. This protein is N-glycosylated, O-glycosylated and phosphorylated. There are three isoforms produced by alternative splicing. A number of forms with varying molecular weights have been observed for this protein. This is possibly the result of differences in glycosylation, phosphorylation and protein cleavage.

Applications:
Suitable for use in Western Blot and direct ELISA. Other applications not tested.

Recommended Dilution:
Optimal dilution determined by the researcher.

Storage and Stability:
Lyophilized powder may be stored at -20C. Stable for 12 months at -20C. Reconstitute with sterile ddH2O. Aliquot to avoid repeated freezing and thawing. Store at -20C. Reconstituted product is stable for 12 months at -20C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.
TypeIsotypeCloneGrade
MabIgG9G338Affinity Purified
SizeStorageShippingSourceHost
100ug-20CBlue IceHumanMouse
Concentration:
~1mg/ml (after reconstitution)
Immunogen:
Partial recombinant protein corresponding to aa445-539 of isoform 2 from human chondrotin sulfate proteoglycan 5 with a GST tag.
Purity:
Purified by Protein G affinity chromatography.
Form
Supplied as a lyophilized powder from PBS, pH 7.2. Reconstitute with 100ul sterile ddH2O.
Specificity:
Recognizes human chondroitin sulfate proteoglycan 5 protein.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.